Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 7;13(46):32734-32771.
doi: 10.1039/d3ra05960j. eCollection 2023 Oct 31.

Recent achievements in the synthesis of benzimidazole derivatives

Affiliations
Review

Recent achievements in the synthesis of benzimidazole derivatives

Nguyen Thi Chung et al. RSC Adv. .

Abstract

Benzimidazoles are a class of heterocyclic compounds in which a benzene ring is fused to the 4 and 5 positions of an imidazole ring. Benzimidazole refers to the parent compound, while benzimidazoles are a class of heterocyclic compounds having similar ring structures, but different substituents. Benzimidazole derivatives possess a wide range of bioactivities including antimicrobial, anthelmintic, antiviral, anticancer, and antihypertensive activities. Many compounds possessing a benzimidazole skeleton have been employed as drugs in the market. The application of benzimidazoles in other fields has also been documented. The synthesis of benzimidazole derivatives has attracted much attention from chemists and numerous articles on the synthesis of this class of heterocyclic compound have been reported over the years. The condensation between 1,2-benzenediamine and aldehydes has received intensive interest, while many novel methods have been developed. In this article, we will give a comprehensive review of studies on the synthesis of benzimidazole, which date back to 2013. We have also tried to describe reaction mechanisms as much as we can. The work might be useful for chemists who work in the synthesis of heterocycles or drug chemistry.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Benzimidazole compounds with antimicrobial activity.
Fig. 2
Fig. 2. Benzimidazole derivatives with anthelmintic activity.
Fig. 3
Fig. 3. Benzimidazole derivatives with antiviral activity.
Fig. 4
Fig. 4. Benzimidazole derivatives with anticancer activity.
Fig. 5
Fig. 5. Benzimidazole derivatives with anticancer activity.
Fig. 6
Fig. 6. Benzimidazole derivatives with other bioactivities.
Scheme 1
Scheme 1
Scheme 2
Scheme 2
Scheme 3
Scheme 3
Scheme 4
Scheme 4
Scheme 5
Scheme 5
Scheme 6
Scheme 6
Scheme 7
Scheme 7
Scheme 8
Scheme 8
Scheme 9
Scheme 9
Scheme 10
Scheme 10
Scheme 11
Scheme 11
Scheme 12
Scheme 12
Scheme 13
Scheme 13
Scheme 14
Scheme 14
Scheme 15
Scheme 15
Scheme 16
Scheme 16
Scheme 17
Scheme 17
Scheme 18
Scheme 18
Scheme 19
Scheme 19
Scheme 20
Scheme 20
Scheme 21
Scheme 21
Scheme 22
Scheme 22
Scheme 23
Scheme 23
Scheme 24
Scheme 24
Scheme 25
Scheme 25
Scheme 26
Scheme 26
Scheme 27
Scheme 27
Scheme 28
Scheme 28
Scheme 29
Scheme 29
Scheme 30
Scheme 30
Scheme 31
Scheme 31
Scheme 32
Scheme 32
Scheme 33
Scheme 33
Scheme 34
Scheme 34
Scheme 35
Scheme 35
Scheme 36
Scheme 36
Scheme 37
Scheme 37
Scheme 38
Scheme 38
Scheme 39
Scheme 39
Scheme 40
Scheme 40
Scheme 41
Scheme 41
Scheme 42
Scheme 42
Scheme 43
Scheme 43
Scheme 44
Scheme 44
Scheme 45
Scheme 45
Scheme 46
Scheme 46
Scheme 47
Scheme 47
Scheme 48
Scheme 48
Scheme 49
Scheme 49
Scheme 50
Scheme 50
Scheme 51
Scheme 51
Scheme 52
Scheme 52
Scheme 53
Scheme 53
Scheme 54
Scheme 54
Scheme 55
Scheme 55
Scheme 56
Scheme 56
Scheme 57
Scheme 57
Scheme 58
Scheme 58
Scheme 59
Scheme 59
Scheme 60
Scheme 60
Scheme 61
Scheme 61
Scheme 62
Scheme 62
Scheme 63
Scheme 63
Scheme 64
Scheme 64
Scheme 65
Scheme 65
Scheme 66
Scheme 66
Scheme 67
Scheme 67
Scheme 68
Scheme 68
Scheme 69
Scheme 69
Scheme 70
Scheme 70
Scheme 71
Scheme 71
Scheme 72
Scheme 72
Scheme 73
Scheme 73
Scheme 74
Scheme 74
Scheme 75
Scheme 75
Scheme 76
Scheme 76
Scheme 77
Scheme 77
Scheme 78
Scheme 78
Scheme 79
Scheme 79
Scheme 80
Scheme 80
Scheme 81
Scheme 81
Scheme 82
Scheme 82
Scheme 83
Scheme 83
Scheme 84
Scheme 84
Scheme 85
Scheme 85
Scheme 86
Scheme 86
Scheme 87
Scheme 87
Scheme 88
Scheme 88
Scheme 89
Scheme 89
Scheme 90
Scheme 90
Scheme 91
Scheme 91
Scheme 92
Scheme 92
Scheme 93
Scheme 93
Scheme 94
Scheme 94
Scheme 95
Scheme 95
Scheme 96
Scheme 96
Scheme 97
Scheme 97
Scheme 98
Scheme 98
Scheme 99
Scheme 99
Scheme 100
Scheme 100
Scheme 101
Scheme 101
Scheme 102
Scheme 102
Scheme 103
Scheme 103
Scheme 104
Scheme 104
Scheme 105
Scheme 105
Scheme 106
Scheme 106
Scheme 107
Scheme 107
Scheme 108
Scheme 108
Scheme 109
Scheme 109
Scheme 110
Scheme 110
Scheme 111
Scheme 111
Scheme 112
Scheme 112
Scheme 113
Scheme 113
Scheme 114
Scheme 114
Scheme 115
Scheme 115
Scheme 116
Scheme 116
Scheme 117
Scheme 117
Scheme 118
Scheme 118
Scheme 119
Scheme 119
Scheme 120
Scheme 120
Scheme 121
Scheme 121
Scheme 122
Scheme 122
Scheme 123
Scheme 123
Scheme 124
Scheme 124
Scheme 125
Scheme 125
Scheme 126
Scheme 126
Scheme 127
Scheme 127
Scheme 128
Scheme 128
Scheme 129
Scheme 129
Scheme 130
Scheme 130
Scheme 131
Scheme 131
Scheme 132
Scheme 132
Scheme 133
Scheme 133
Scheme 134
Scheme 134
Scheme 135
Scheme 135
Scheme 136
Scheme 136
Scheme 137
Scheme 137
Scheme 138
Scheme 138
Scheme 139
Scheme 139
Scheme 140
Scheme 140
Scheme 141
Scheme 141
Scheme 142
Scheme 142
Scheme 143
Scheme 143
Scheme 144
Scheme 144
Scheme 145
Scheme 145
Scheme 146
Scheme 146
Scheme 147
Scheme 147
Scheme 148
Scheme 148
Scheme 149
Scheme 149
None
Nguyen Thi Chung
None
Vo Cong Dung
None
Dau Xuan Duc

References

    1. Kathrotiya H. G. Patel M. P. J. Chem. Sci. 2013;125:993–1001.
    1. Vasantha K. Basavarajaswamy G. Vaishali Rai M. Boja P. Pai V. R. Shruthi N. Bhat M. Bioorg. Med. Chem. Lett. 2015;25:1420–1426. - PubMed
    1. Yadav S. Narasimhan B. Lim S. M. Ramasamy K. Vasudevan M. Shah S. A. A. Mathur A. J. Basic Appl. Sci. 2018;5:100–109.
    1. Shaikh I. N. Hosamani K. M. Kurjogi M. M. Arch. Pharm. 2018;351:1700205. - PubMed
    1. Faruk A. Biplab K. D. Kamal S. Arpita C. Pallab K. Int. J. Drug Res. Technol. 2014;4:31–38.